These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 24079361)
1. Development and evaluation of oral osmotic pump of butorphanol tartrate. Shah B; Raichandani Y; Misra A Pharm Dev Technol; 2014 Nov; 19(7):868-80. PubMed ID: 24079361 [TBL] [Abstract][Full Text] [Related]
2. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation. Liu H; Yang XG; Nie SF; Wei LL; Zhou LL; Liu H; Tang R; Pan WS Int J Pharm; 2007 Mar; 332(1-2):115-24. PubMed ID: 17052871 [TBL] [Abstract][Full Text] [Related]
3. Formulation and evaluation of controlled porosity osmotic pump for oral delivery of ketorolac. Dasankoppa FS; Ningangowdar M; Sholapur H J Basic Clin Pharm; 2012 Dec; 4(1):2-9. PubMed ID: 24808662 [TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of osmotically controlled oral drug delivery system of glipizide. Verma RK; Garg S Eur J Pharm Biopharm; 2004 May; 57(3):513-25. PubMed ID: 15093601 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of butorphanol delivered with an osmotic pump during a seven-day period in common peafowl (Pavo cristatus). Clancy MM; KuKanich B; Sykes JM Am J Vet Res; 2015 Dec; 76(12):1070-6. PubMed ID: 26618732 [TBL] [Abstract][Full Text] [Related]
6. Controlled porosity solubility modulated osmotic pump tablets of gliclazide. Banerjee A; Verma PR; Gore S AAPS PharmSciTech; 2015 Jun; 16(3):554-68. PubMed ID: 25378281 [TBL] [Abstract][Full Text] [Related]
7. Development and Evaluation of a Once-Daily Controlled Porosity Osmotic Pump of Tapentadol Hydrochloride. Thakkar HP; Pancholi N; Patel CV AAPS PharmSciTech; 2016 Oct; 17(5):1248-60. PubMed ID: 26677859 [TBL] [Abstract][Full Text] [Related]
8. Development of an osmotic pump system for controlled delivery of diclofenac sodium. Emara LH; Taha NF; Badr RM; Mursi NM Drug Discov Ther; 2012 Oct; 6(5):269-77. PubMed ID: 23229148 [TBL] [Abstract][Full Text] [Related]
9. A novel solubility-modulated granules through porosity osmotic pump for controlled carvedilol delivery. Song QL; Li P; Li YM Pharm Dev Technol; 2012; 17(6):666-76. PubMed ID: 21486184 [TBL] [Abstract][Full Text] [Related]
10. Micro-porous surfaces in controlled drug delivery systems: design and evaluation of diltiazem hydrochloride controlled porosity osmotic pump using non-ionic surfactants as pore-former. Adibkia K; Ghanbarzadeh S; Shokri MH; Arami Z; Arash Z; Shokri J Pharm Dev Technol; 2014 Jun; 19(4):507-12. PubMed ID: 23763379 [TBL] [Abstract][Full Text] [Related]
11. Development and biopharmaceutical evaluation of extended release formulation of tramadol hydrochloride based on osmotic technology. Kumar P; Singh S; Mishra B Acta Pharm; 2009 Mar; 59(1):15-30. PubMed ID: 19304555 [TBL] [Abstract][Full Text] [Related]
12. Push-pull osmotic pump for zero order delivery of lithium carbonate: development and in vitro characterization. Patel V; Chudasama A; Nivsarkar M; Vasu K; Shishoo C Pharm Dev Technol; 2012; 17(3):375-82. PubMed ID: 21284541 [TBL] [Abstract][Full Text] [Related]
13. Modified push-pull osmotic system for simultaneous delivery of theophylline and salbutamol: development and in vitro characterization. Prabakaran D; Singh P; Kanaujia P; Jaganathan KS; Rawat A; Vyas SP Int J Pharm; 2004 Oct; 284(1-2):95-108. PubMed ID: 15454301 [TBL] [Abstract][Full Text] [Related]
14. Serum concentrations and analgesic effects of liposome-encapsulated and standard butorphanol tartrate in parrots. Sladky KK; Krugner-Higby L; Meek-Walker E; Heath TD; Paul-Murphy J Am J Vet Res; 2006 May; 67(5):775-81. PubMed ID: 16649909 [TBL] [Abstract][Full Text] [Related]
15. Experiment on formulation and drug release behavior of porosity asymmetric membrane capsules in vitro. Fu HX; Li H; Zhang FZ; Zhao YZ; Wan CW; Chen MT; Jia XC; Yan L; Sun CC; Xu YY Drug Dev Ind Pharm; 2012 Jun; 38(6):670-8. PubMed ID: 22469006 [TBL] [Abstract][Full Text] [Related]
16. Formulation and optimization of porous osmotic pump-based controlled release system of oxybutynin. Kanagale P; Lohray BB; Misra A; Davadra P; Kini R AAPS PharmSciTech; 2007 Jul; 8(3):E53. PubMed ID: 17915803 [TBL] [Abstract][Full Text] [Related]
17. Micro-suspension coating method: a new approach in formulation and development of controlled porosity osmotic pump systems. Adibkia K; Hanaee J; Ghanbarzadeh S; Bahrami R; Shokri J Drug Res (Stuttg); 2014 Apr; 64(4):203-7. PubMed ID: 24026954 [TBL] [Abstract][Full Text] [Related]
18. Design and evaluation of osmotic pump-based controlled release system of Ambroxol Hydrochloride. Cheng X; Sun M; Gao Y; Cao F; Zhai G Pharm Dev Technol; 2011 Aug; 16(4):392-9. PubMed ID: 20429827 [TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of controlled porosity osmotic pump for nifedipine and metoprolol combination. Kumaravelrajan R; Narayanan N; Suba V Lipids Health Dis; 2011 Apr; 10():51. PubMed ID: 21477386 [TBL] [Abstract][Full Text] [Related]
20. Transnasal butorphanol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute pain management. Gillis JC; Benfield P; Goa KL Drugs; 1995 Jul; 50(1):157-75. PubMed ID: 7588085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]